Abstract: This invention relates to a novel strain of lactobacillus, called Lactobacillus acidophilus EUVAG, and topical vaginal pharmaceutical formulations containing it, for use in all forms of dysbiosis and variations in vaginal pH which can cause recurrent bacterial or fungal vaginal infections.